Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data UTSTARCOM HOLDINGS CORP. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
86.5
98.3
116
65.6
24.3
15.9
14.1
15.8
10.9
8.98
Cost of revenue
58.2
65.1
83.7
41.5
20.8
17
11.4
11.4
7.97
7.93
Gross profit
28.4
33.1
32.3
24.2
3.53
-1.08
2.67
4.39
2.91
1.05
Research and development
8.5
9.85
12.7
14.5
8.08
6.89
4.76
5.88
5.09
4.64
Selling, general and administrative
18.1
16.8
15.2
15.8
18.7
Operating expenses
26.6
26.6
27.9
30.3
26.8
4.24
7.05
11.2
10.2
9.61
Operating income
1.71
6.52
4.37
-6.14
-23.2
-5.32
-4.39
-6.81
-7.33
-8.56
Interest expense
0.06
0.05
0.05
0.02
0.01
Interest income
0.87
1.18
1.75
1.34
0.99
1.14
2.15
2.21
2.79
2.24
Other non-operating income
2.75
2.98
-0.64
0.87
-2.17
1.65
-0.71
2.02
0.86
-0.01
Pre-tax income
0.92
8.24
4.44
-3.94
-25.5
-2.53
-2.94
-2.58
-3.69
-6.33
Income tax
0.79
1.26
-0.38
-0.03
-1.78
3.29
2.06
1.27
0.68
1.62
Net income to minority interests
-0.16
Net income
0.29
6.98
4.82
-3.91
-23.7
-5.83
-5
-3.85
-4.37
-7.95
EBITDA
2.92
7.14
5.07
-5.49
-22.7
-4.95
-4.18
-6.58
-7.06
-8.35
EPS, basic
0.04
0.80
0.56
-0.44
-2.64
-0.65
-0.55
-0.42
-0.48
-0.87
EPS, diluted
0.04
0.76
0.52
-0.44
-2.64
-0.65
-0.55
-0.42
-0.48
-0.87
Shares, basic (weighted)
8.95
8.87
8.91
8.89
8.97
9.01
9.06
9.11
9.15
9.19
Shares, diluted (weighted)
9.1
9.04
9.08
8.89
8.97
9.01
9.06
9.11
9.15
9.19
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
83.9
79.7
57
35
34.2
53.8
54.5
50
43.9
33.8
Short-term investments
2.1
0.17
0.7
Receivables
18.3
16.9
60.7
77.8
49.6
27.4
11.9
8.38
4.85
Inventory
22.6
17.1
26.4
6.14
6.7
1.54
1.27
0.8
1.94
1.32
Other current assets
0.81
0.98
0.79
1.36
1.05
0.8
0.45
0.28
0.61
0.97
Total current assets
163
167
160
137
110
97.8
81.8
70.6
63.1
51.6
Property, plant and equipment
1.61
1.71
1.26
1.09
0.62
0.6
0.6
0.61
0.48
0.71
Lease right-of-use assets
2.86
1.18
4.73
2.97
2.65
1.4
0.97
Long-term investments
7.75
5.86
5.22
3.13
0
0
Other non-current assets
0.68
0.53
0.67
0.74
0.67
0.62
0.54
0.51
0.47
0.55
Total assets
179
187
177
151
119
108
89.2
77.5
68.2
55.9
Accounts payable
22.5
27.5
50.8
30.9
25.1
19
13
7.96
7.01
4.17
Accrued liabilities
5.9
7.04
5.22
2.86
2.93
2.51
2.21
2.5
1.51
1.41
Deferred revenue
10.8
7.29
3.95
1.32
0.41
0.08
0.08
0.07
0.06
0.01
Total current liabilities
87.2
88.3
69.8
49
40
35.4
28.9
23.4
21.5
18
Lease liabilities
1.36
0.26
3.5
1.89
1.66
0.4
0.33
Other non-current liabilities
4.98
3.65
2.5
1.35
1
0.98
1
1.02
1.04
1.06
Total liabilities
96
96.1
75.3
52.1
41.3
39.9
31.8
26.1
23
19.4
Paid-in capital
1,262
1,263
1,264
1,266
1,266
1,267
1,267
1,268
1,268
1,268
Retained earnings
-1,233
-1,226
-1,213
-1,217
-1,240
-1,246
-1,251
-1,255
-1,259
-1,267
Treasury stock
-8.23
-8.37
-10.9
-11.9
-12.3
-12.3
-12.3
-12.3
-12.3
-12.3
Other comprehensive income
62
62.4
61.6
62.1
63.7
59.9
53.4
50.9
49
48.1
Shareholders' equity
82.7
91
102
99.2
77.4
68.4
57.5
51.4
45.2
36.5
Total equity
82.7
91
102
99.2
77.4
68.4
57.5
51.4
45.2
36.5
Total liabilities and equity
179
187
177
151
119
108
89.2
77.5
68.2
55.9
Shares outstanding
8.81
8.88
8.83
8.88
35.9
9.03
9.07
9.11
9.16
9.19
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
0.13
6.98
4.82
-3.91
-23.7
-5.83
-5
-3.85
-4.37
-7.95
Depreciation and amortization
1.21
0.63
0.7
0.64
0.57
0.37
0.21
0.23
0.28
0.21
Stock-based compensation
2.24
0.87
1.1
1.4
0.7
0.5
0.6
0.29
0.12
0.11
Deferred income tax
0.77
-1.09
0.51
0.8
-2.83
2.05
1.14
0.28
0.15
0.23
Change in receivables
-1.97
1.41
-44.8
-21.6
18.8
31.3
19
4.8
3.57
-0.2
Change in payables
7.39
5.18
23.2
-19.9
-5.75
-6.09
-6.06
-5.02
-0.95
-2.84
Cash from operations
5.73
3.84
-26.1
-24.1
-3.4
19.8
7.28
-4.48
-4.46
-8.82
Capital expenditures
-1.53
-0.73
-0.23
-0.51
-0.12
-0.35
-0.25
-0.26
-0.16
-0.42
Acquisitions
-0.67
Purchases of investments
-3.16
-0.04
-0.62
Cash from investing
5.94
-3.88
2.25
-0.51
1.98
1.75
-0.25
-0.26
-0.16
-1.04
Stock issued
0.11
0.1
0.06
0.02
0
0
0
Share buybacks
-4.1
-0.14
-2.53
-1.05
-0.37
-0.01
Cash from financing
-4.4
-0.03
-2.42
-0.99
-0.37
0.01
0
0
0
Net change in cash
5.55
2.05
-27
-25.1
-0.22
17.9
0.58
-7.21
-6.5
-10.8
Free cash flow
4.21
3.11
-26.3
-24.7
-3.52
19.5
7.03
-4.73
-4.62
-9.24
Interest paid
0.06
0.05
0.05
0.02
0.01
Income taxes paid
3.31
2.01
1.22
1.4
2.1
0.8
1.34
0.96
0.85
0.8
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $2.32 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
11.7%
Gross profit / revenue.
Operating margin
-95.3%
Operating income / revenue.
EBITDA margin
-93.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-70.5%
Pre-tax income / revenue.
Net margin
-88.5%
Net income / revenue.
FCF margin
-103.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-98.3%
Cash from operations / revenue.
Return on equity (ROE)
-19.5%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-12.8%
Net income / average total assets.
Return on invested capital (ROIC)
-338.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
51.7%
Research and development expense / revenue.
Stock-based pay / revenue
1.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
4.7%
Capital expenditures / revenue.
D&A / revenue
2.3%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-17.5%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-13.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-18.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
-63.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-26.7%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-21.5%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-19.3%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-14.0%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-14.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-18.0%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-14.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-14.0%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.4%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
0.5%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
0.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.86x
Current assets / current liabilities.
Quick ratio
1.92x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.92x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.87
Net income per basic share, as reported (split-adjusted).
Revenue per share
$0.98
Revenue / diluted weighted shares.
FCF per share
-$1.01
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.96
Cash from operations / diluted weighted shares.
Book value per share
$3.97
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
2.45x
Market cap / revenue.
P/B
0.60x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.60x
Market cap / tangible book value, when positive.
FCF yield
-42.0%
Free cash flow / market cap.
Earnings yield
-36.1%
Net income / market cap (the inverse of P/E).
What was UTSTARCOM HOLDINGS CORP.'s revenue in fiscal 2025?
UTSTARCOM HOLDINGS CORP. reported revenue of $9.0M for fiscal 2025, 17.5% lower than the year before.
Was UTSTARCOM HOLDINGS CORP. profitable in fiscal 2025?
No. It reported a net loss of $8.0M.
How much free cash flow did UTSTARCOM HOLDINGS CORP. generate in fiscal 2025?
Cash from operations of $8.8M minus capital expenditures of $423.0K left free cash flow of -$9.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.